These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 29606134)
21. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney. Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364 [TBL] [Abstract][Full Text] [Related]
22. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma. Li G; Barthelemy A; Feng G; Gentil-Perret A; Peoc'h M; Genin C; Tostain J Histopathology; 2007 Apr; 50(5):642-7. PubMed ID: 17394501 [TBL] [Abstract][Full Text] [Related]
24. Parvalbumin is constantly expressed in chromophobe renal carcinoma. Martignoni G; Pea M; Chilosi M; Brunelli M; Scarpa A; Colato C; Tardanico R; Zamboni G; Bonetti F Mod Pathol; 2001 Aug; 14(8):760-7. PubMed ID: 11504835 [TBL] [Abstract][Full Text] [Related]
25. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma. Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598 [TBL] [Abstract][Full Text] [Related]
26. CD2-associated protein in human urogenital system and in adult kidney tumours. Tienari J; Lehtonen S; Lehtonen E Virchows Arch; 2005 Apr; 446(4):394-401. PubMed ID: 15785926 [TBL] [Abstract][Full Text] [Related]
27. Vinculin: its possible use as a marker of normal collecting ducts and renal neoplasms with collecting duct system phenotype. Kuroda N; Naruse K; Miyazaki E; Hayashi Y; Yoshikawa C; Ashida S; Moriki T; Yamasaki Y; Numoto S; Yamamoto Y; Yamasaki I; Hiroi M; Shuin T; Enzan H Mod Pathol; 2000 Oct; 13(10):1109-14. PubMed ID: 11048805 [TBL] [Abstract][Full Text] [Related]
28. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma. Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941 [TBL] [Abstract][Full Text] [Related]
29. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT. Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms. Gupta R; Balzer B; Picken M; Osunkoya AO; Shet T; Alsabeh R; Luthringer D; Paner GP; Amin MB Am J Surg Pathol; 2009 Feb; 33(2):241-7. PubMed ID: 18941400 [TBL] [Abstract][Full Text] [Related]
31. Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue. Reid-Nicholson MD; Motiwala N; Drury SC; Peiper SC; Terris MK; Waller JL; Ramalingam P Ann Diagn Pathol; 2011 Feb; 15(1):37-45. PubMed ID: 21238914 [TBL] [Abstract][Full Text] [Related]
32. GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics. Mantilla JG; Antic T; Tretiakova M Hum Pathol; 2017 Aug; 66():152-158. PubMed ID: 28705707 [TBL] [Abstract][Full Text] [Related]
33. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma. Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535 [TBL] [Abstract][Full Text] [Related]
34. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma. Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273 [TBL] [Abstract][Full Text] [Related]
35. [Non clear cell renal cell carcinoma. 2008 update in renal tumor pathology]. Sibony M; Vieillefond A Ann Pathol; 2008 Oct; 28(5):381-401. PubMed ID: 19068393 [TBL] [Abstract][Full Text] [Related]
36. Expression of GLUT1 in primary renal tumors: morphologic and biologic implications. Ozcan A; Shen SS; Zhai QJ; Truong LD Am J Clin Pathol; 2007 Aug; 128(2):245-54. PubMed ID: 17638658 [TBL] [Abstract][Full Text] [Related]
37. Membrane bile acid receptor TGR5 predicts good prognosis in ampullary adenocarcinoma patients with hyperbilirubinemia. Chen MC; Chen YL; Wang TW; Hsu HP; Lai MD Oncol Rep; 2016 Oct; 36(4):1997-2008. PubMed ID: 27510297 [TBL] [Abstract][Full Text] [Related]
38. Protein expression and gene mutation status of KIT and PDGFRA in renal cell carcinoma. Terada T Histol Histopathol; 2012 Mar; 27(3):297-302. PubMed ID: 22237707 [TBL] [Abstract][Full Text] [Related]
39. Inactivation of BHD in sporadic renal tumors. Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635 [TBL] [Abstract][Full Text] [Related]
40. Expression of S-100 protein in renal cell neoplasms. Lin F; Yang W; Betten M; Teh BT; Yang XJ; Hum Pathol; 2006 Apr; 37(4):462-70. PubMed ID: 16564922 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]